Brief: Valeo Pharma Says Submitted Hesperco Natural Product License Application For Approval To Health Canada
24/08/2020 12:37
Aug 24 (Reuters) - Valeo Pharma Inc VPH.CD :
* VALEO PHARMA HAS SUBMITTED HESPERCO™ NATURAL PRODUCT
LICENSE
APPLICATION FOR APPROVAL TO HEALTH CANADA
Source text for Eikon: ID:nCNWYLH3da
Further company coverage: VPH.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valeo Pharma
See all newsBrief: Valeo Pharma Says Co Initiates Restructuring Proceedings
Brief: Valeo Pharma Amends Credit Facility With Sagard Healthcare Royalty Partners
Brief: Valeo Pharma Announces Restructuring Of Commercial Field Operations To Support Path To Profitability
Brief: Valeo Pharma Announces Appointment Of Mr. Al Moghaddam To Board Of Directors
Brief: Valeo Pharma Amends Agreement With Novartis Pharmaceuticals Canada